Bayer explores possible sale of diabetes device unit -Bloomberg

Nov 24 (Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

from Reuters: Mergers News http://ift.tt/11ruP5v